Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025)

Biofrontera has reported Other Non-Current Liabilities over the past 6 years, most recently at $351000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 71.92% year-over-year to $351000.0; the TTM value through Dec 2025 reached $351000.0, down 71.92%, while the annual FY2025 figure was $351000.0, 71.92% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $351000.0 at Biofrontera, down from $833000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $11.7 million in Q1 2024 and troughed at $21000.0 in Q4 2022.
  • A 5-year average of $3.3 million and a median of $1.5 million in 2023 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 99.63% in 2022 and later surged 48779.17% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $5.6 million in 2021, then plummeted by 99.63% to $21000.0 in 2022, then surged by 19947.62% to $4.2 million in 2023, then tumbled by 70.31% to $1.2 million in 2024, then plummeted by 71.92% to $351000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BFRI at $351000.0 in Q4 2025, $833000.0 in Q3 2025, and $548000.0 in Q2 2025.